Growth Metrics

Caribou Biosciences (CRBU) Shares Issued (2020 - 2026)

Caribou Biosciences (CRBU) reported Shares Issued of $468000.0 for Q1 2026, down 37.18% on a QoQ basis from $745000.0 in Q4 2025.

Caribou Biosciences (CRBU) has 6 years of Shares Issued data on file, last reported at $468000.0 in Q1 2026.

  • Quarterly Shares Issued changed N/A year-over-year to $468000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 68.6% YoY) and the FY2025 annual result came in at $745000.0, down 95.1% from the prior year.
  • Shares Issued retreated to $468000.0 in Q1 2026 per CRBU's latest filing, from $745000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $17.5 million in Q2 2023 and bottomed at -$1.0 million in Q4 2023.
  • The 4-year median for Shares Issued is $745000.0 (2025), against an average of $4.7 million.
  • The widest annual swing landed in 2024, when Shares Issued surged 483.61%; it then plunged 80.71% in 2025.
  • Tracing CRBU's Shares Issued over 4 years: stood at -$1.0 million in 2023, then surged by 483.61% to $3.9 million in 2024, then sank by 80.71% to $745000.0 in 2025, then sank by 37.18% to $468000.0 in 2026.
  • Per Business Quant, the three latest CRBU Shares Issued figures stand at $468000.0 (Q1 2026), $745000.0 (Q4 2025), and $3.9 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 5.40 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 27.00 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 163.10 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 13.16 Mn
10 Caribou Biosciences 232.46 Mn 114.84 Mn - 468,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 468,000.00
Mar 31, 2026 468,000.00
Dec 31, 2025 745,000.00
Dec 31, 2025 745,000.00
Dec 31, 2024 3.86 Mn
Dec 31, 2024 3.86 Mn
Mar 31, 2024 11.33 Mn
Mar 31, 2024 11.33 Mn
Dec 31, 2023 -1.01 Mn
Dec 31, 2023 -1.01 Mn
Sep 30, 2023 252,000.00
Sep 30, 2023 252,000.00
Jun 30, 2023 17.50 Mn
Jun 30, 2023 17.50 Mn
Sep 30, 2021 319.89 Mn
Sep 30, 2021 319.89 Mn
Dec 31, 2020 110,000.00
Dec 31, 2020 110,000.00
Sep 30, 2020 139,000.00
Sep 30, 2020 139,000.00